Navigation Links
ATS Medical Provides Update on Clinical Progress of ATS 3f Enable Aortic Bioprosthesis
Date:11/28/2007

to clinical trials to development projects that incorporate less invasive valve replacement technology. ATS Medical's focus on serving the cardiac surgery community is further strengthened by offerings that include ATS Simulus(R) annuloplasty products for heart valve repair, ATS CryoMaze(TM) surgical ablation products, and RTI-Cardiovascular for allograft tissue services. The ATS Medical web site is http://www.atsmedical.com.

Safe Harbor

This Press Release contains forward-looking statements that may include statements regarding intent, belief or current expectations of the Company and its management. Actual results could differ materially from those projected in the forward looking statements as a result of a number of important factors, including the results of clinical trials, the timing of regulatory approvals, the integration of 3f Therapeutics and the surgical cryoablation business of CryoCath Technologies, Inc., regulatory actions, competition, pricing pressures, supplier actions and management of growth. For a discussion of these and other risks and uncertainties that could affect the Company's activities and results, please refer to the Company's filings with the Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2006 and its most recent quarterly report on Form 10-Q.


'/>"/>
SOURCE ATS Medical Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2008)...an farm, FDA announces , , FRIDAY, July...ering the first big clue in the nationwide salmone...ay that tainted jalapeno peppers had been definiti...d and Drug Administration gave the all-clear to ja...tes, but warned consumers to avoid any raw jalapen...
(Date:7/25/2008)...ter & Olsen LLP has filed a,class action lawsuit a...,"Company") (Nasdaq: ARTC ) and certain of its of...District of Texas on behalf of all persons or,enti...m January 24, 2008,through July 18, 2008 (the "Com... or entities who purchased call options or sold pu...
(Date:7/25/2008)...inancial results -, LAVAL, QC, July 25 /PRNewswir...DSS) today announced that it will host a conferenc...scuss its second quarter 2008,financial results. L...cial,results via news release at approximately 7:0...ll by telephone, dial 416-646-3095 or,1-800-814-48...
(Date:7/25/2008)...FirstCall/ -- Thoratec,Corporation (Nasdaq: THOR ...atory support therapies to save, support and resto...port its operating results for the second,quarter ...uly 31., The company will hold a conference call ...ivities to all interested parties at 1:30 p.m.,Pa...
Breaking Medicine News(10 mins):Health News:Mexican Peppers ID'd as Salmonella Culprits 2Health News:Mexican Peppers ID'd as Salmonella Culprits 3Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2
...tics show that drug deaths in Scotland have droppe...rom drugs in Scotland in 2005 compared with 356 in...is a tragedy and reminds us that drug abuse is a b...es and communities across Scotland," said Deputy J...
...l of growing by a whopping 25 percent annually to ...by 2012, Tourism Minister Ambika Soni said Wednesd... at the response from foreign patients, we estimat...llion annually by 2012," said Soni while releasing...
... brain injury, the simplest movements like putting...to open a door can be daunting for patients.// Com...lternative to traditional physical rehabilitation ...lled with an antispasmodic drug that is implanted ...
...ied after getting an overdose of chemotherapy drug...ly, yesterday.// Dr. Tony Fields told a news conf...s a most unfortunate incident. She died from inter...e.” "This is one of our worst nightmares," said Fi...
Other Medicine News:Health News:Medical Tourism can Fetch Rs.100 bn Annually by 2012 2Health News:Medical Tourism can Fetch Rs.100 bn Annually by 2012 3Health News:Computer Assisted Neuro-Rehabilitation Devices Way of the Future 2Health News:Overdose of Chemotherapy Drug kills a woman 2
(Date:7/23/2008)...Newswire-FirstCall/ -- Dendreon Corporation,(Nasda...ependent Data,Monitoring Committee (IDMC) to revie...survival relating to the Company,s Phase 3 IMPACT ...nt, also known as D9902B) clinical trial,of PROVEN...vestigational,active cellular immunotherapy for th...
(Date:7/22/2008)...sults from a multi-center 293-patient European, t... Exchange Symbol: CYT, MONTREAL, July 22 /PRNewsw...e global leader in cryotherapy products to treat c...reviously presented from three,European study cent...(R),were published earlier today in the Journal o...
(Date:7/22/2008)...scuss Development Plan Completed Successfully, DU...marin Corporation,plc (NASDAQ: AMRN ) today annou...at the U.S. Food and Drug Administration (FDA) to ...the treatment of,hypertriglyceridemia. Following t...se 3 with AMR101 in hypertriglyceridemia., Dr. De...
(Date:7/22/2008)...g Lantus(R) and Apidra(R) Resulted in Significant,...s, Whatever the Algorithm ...wire/ -- Results from the "Adjust to,Target in Typ...Carbohydrate,Counting for Adjustment of Mealtime I...rican Diabetes Association,s (ADA) medical journal...
Breaking Medicine Technology:Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4ViroPharma to Present at Two Upcoming Healthcare Conferences 1898 1ViroPharma to Present at Two Upcoming Healthcare Conferences 1898 2Story ideas from the Journal of Biological Chemistry 1304 1Story ideas from the Journal of Biological Chemistry 1304 2Serum carcinoembryonic antigen level can reflect adrenal adenoma 6784 1Serum carcinoembryonic antigen level can reflect adrenal adenoma 6784 2Proposal to step up cardiovascular disease research 1299 1Proposal to step up cardiovascular disease research 1299 2
...asound Demonstrates Utility in Evaluating Drug,Eff...ntial for HDL,Therapy , ,PLEASANTON, CA, Mar 30, 2... Sciences, Inc. (NASDAQ: LIPD) Dr. H. Bryan Brewer..., Inc., concluded from,the wide range of presentat...(ACC) Meeting in New Orleans that the rationale fo...
...e Astellas Commitment to Overcoming Critical,Short... April 02, 2007 /PRNewswire/ --Study results,prese...robiology,and Infectious Diseases (ECCMID) show th...icafungin, both have the potential,to meet a signi...pital-acquired infections (HAIs). , Hospital-acqui...
Other Medicine Technology:Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 2Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 3Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 4Presentations at American College of Cardiology Meeting Highlight,New Opportunities for HDL Therapy 5Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 2Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 3Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 4Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease 5
Delicate curved shafts with light crisscross serrations. Serrated handle with polished finish. Most popular size or model.
Delicate cross serrated lightly curved tips with serrated handle and polished finish. Most popular size or model.
Delicate lightly curved tips, 1 x 2 mouse style teeth. Serrated handle with polished finish.
Straight tubular shaft with delicate 1.5 mm oval jaws. Squeeze barrel style handle with tip guard and polished finish.
Medicine Products: